Xiaodan Yang Selected Research

Neoplasms (Cancer)

1/2022	Preclinical Pharmacokinetics, Biodistribution, and Acute Toxicity Evaluation of Caerin 1.9 Peptide in Sprague Dawley Rats.
1/2022	Caerin 1 Peptides, the Potential Jack-of-All-Trades for the Multiple Antibiotic-Resistant Bacterial Infection Treatment and Cancer Immunotherapy.
1/2022	LncRNA MALAT1 regulates METTL3-mediated PD-L1 expression and immune infiltrates in pancreatic cancer.
11/2021	Calcium channel α2δ1 subunit is a functional marker and therapeutic target for tumor-initiating cells in non-small cell lung cancer.
1/2021	Intratumoral injection of caerin 1.1 and 1.9 peptides increases the efficacy of vaccinated TC-1 tumor-bearing mice with PD-1 blockade by modulating macrophage heterogeneity and the activation of CD8+ T cells in the tumor microenvironment.
1/2021	The α2δ1 subunit of the voltage-gated calcium channel acts as a potential candidate for breast cancer tumor initial cells biomarker.
11/2020	AMP‑activated protein kinase family member 5 is an independent prognostic indicator of pancreatic adenocarcinoma: A study based on The Cancer Genome Atlas.
10/2020	Targeting interleukin-10 signalling for cancer immunotherapy, a promising and complicated task.
8/2020	MG132 inhibits the expression of PBX3 through miRNAs by targeting Argonaute2 in hepatoma cells.
1/2018	AMPK-related kinase 5 (ARK5) enhances gemcitabine resistance in pancreatic carcinoma by inducing epithelial-mesenchymal transition.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaodan Yang Research Topics

Disease

14	Neoplasms (Cancer) 01/2022 - 12/2013
6	Pancreatic Neoplasms (Pancreatic Cancer) 05/2024 - 01/2018
4	Obesity 02/2024 - 04/2023
4	Inflammation (Inflammations) 08/2023 - 01/2019
4	Tics (Tic) 01/2023 - 01/2019
3	Dysbiosis 01/2023 - 01/2022
3	Stroke (Strokes) 01/2022 - 04/2020
3	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 03/2020
3	Carcinogenesis 01/2021 - 11/2018
3	Adenocarcinoma of Lung 01/2021 - 05/2015
3	Infections 10/2020 - 01/2018
3	Sarcoma (Soft Tissue Sarcoma) 04/2016 - 05/2015
2	Adenocarcinoma 05/2024 - 11/2020
2	Non-alcoholic Fatty Liver Disease 02/2024 - 02/2024
2	Insulin Resistance 02/2024 - 01/2022
2	Body Weight (Weight, Body) 08/2023 - 01/2022
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2021 - 01/2018
2	Vesicular Stomatitis 02/2016 - 01/2016
1	Carcinoma (Carcinomatosis) 05/2024
1	Thrombosis (Thrombus) 04/2024
1	Autoimmune Hepatitis 04/2024
1	Necrosis 04/2024
1	Liver Diseases (Liver Disease) 02/2024
1	Metabolic Diseases (Metabolic Disease) 02/2024
1	Encephalitis (Encephalitis, Rasmussen) 01/2024
1	Guillain-Barre Syndrome 01/2024
1	Miller Fisher Syndrome (Fisher Syndrome) 01/2024
1	Lung Injury 12/2023
1	Pancreatitis 12/2023
1	Fatty Liver 08/2023
1	Visceral Pain 01/2023
1	Asphyxia (Suffocation) 01/2023
1	Colitis 01/2023
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2022
1	Massive Hepatic Necrosis 04/2022
1	Condylomata Acuminata (Genital Wart) 01/2022
1	Endotoxemia 01/2022
1	Ischemic Stroke 01/2022
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Diabetes Mellitus 01/2022

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2016
4	MicroRNAs (MicroRNA)IBA 12/2023 - 11/2018
4	Calcium Channels (Calcium Channel)IBA 01/2023 - 01/2019
3	Interleukin-10 (Interleukin 10)IBA 04/2024 - 10/2020
3	LipopolysaccharidesIBA 04/2024 - 01/2023
3	AntigensIBA 02/2024 - 04/2023
3	Therapeutic UsesIBA 02/2024 - 11/2021
3	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2021
3	Messenger RNA (mRNA)IBA 12/2023 - 08/2020
3	VaccinesIBA 01/2022 - 10/2020
2	InterferonsIBA 04/2024 - 01/2018
2	Concanavalin AIBA 04/2024 - 04/2022
2	CytokinesIBA 04/2022 - 10/2020
2	Indicators and Reagents (Reagents)IBA 01/2022 - 11/2020
2	Peptides (Polypeptides)IBA 01/2022 - 01/2021
2	Immune Checkpoint InhibitorsIBA 01/2022 - 10/2020
2	Gemcitabine FDA Link 10/2021 - 01/2018
2	Phosphotransferases (Kinase)IBA 01/2018 - 01/2017
2	Tyrosine Kinase InhibitorsIBA 09/2017 - 01/2016
2	Antiviral Agents (Antivirals)IBA 02/2016 - 01/2016
1	ApolipoproteinsIBA 05/2024
1	Apolipoproteins E (ApoE)IBA 05/2024
1	Protein Disulfide-IsomerasesIBA 04/2024
1	Small Interfering RNA (siRNA)IBA 04/2024
1	DisulfidesIBA 04/2024
1	histidine-rich proteinsIBA 04/2024
1	BerberineIBA 04/2024
1	Transaminases (Aminotransferases)IBA 04/2024
1	Interleukin-17 (Interleukin 17)IBA 04/2024
1	LipidsIBA 02/2024
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 02/2024
1	AntibodiesIBA 01/2024
1	Sulfoglycosphingolipids (Sulfatides)IBA 01/2024
1	(1-6)-alpha-glucomannan (glucomannan)IBA 08/2023
1	OligosaccharidesIBA 08/2023
1	Blood Glucose (Blood Sugar)IBA 08/2023
1	Anesthetics (Anesthetic Agents)IBA 01/2023
1	Remifentanil (Ultiva)FDA Link 01/2023
1	PlasticsIBA 01/2023
1	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 01/2023
1	SubtilisinIBA 01/2023
1	Protein Isoforms (Isoforms)IBA 01/2023
1	Small Cytoplasmic RNAIBA 11/2022
1	Metformin (Glucophage)FDA LinkGeneric 04/2022
1	Saline SolutionIBA 04/2022
1	Long Noncoding RNAIBA 01/2022
1	6-methyladenineIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Cytidine Triphosphate (CTP)IBA 01/2022
1	EndotoxinsIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	CalciumIBA 11/2021

Therapy/Procedure

12	Therapeutics 02/2024 - 01/2016
5	Drug Therapy (Chemotherapy) 01/2022 - 09/2017
5	Immunotherapy 01/2022 - 10/2020
2	Transplantation 02/2024 - 01/2021
1	Fecal Microbiota Transplantation 04/2023